Table 3.
Adjusted hazard ratios for lymphoid malignancy and all malignancies (excluding lymphoid malignancy)
| Variable | Adjusted HRafor lymphoid malignancy (95%CI) | Pvalue | Adjusted HRafor all malignancies (95%CI) | Pvalue | |
|---|---|---|---|---|---|
| Herpes zoster |
|
|
|
|
|
| |
No |
Reference |
|
Reference |
|
| |
Yes |
1.68 (1.35-2.42) |
0.0026 |
1.00 (0.91-1.05) |
0.872 |
| Charlson comorbidity indexb |
|
|
|
|
|
| |
No |
Reference |
|
Reference |
|
| |
Yes |
2.33 (1.66-3.27) |
<0.0001 |
2.92 (2.75-3.11) |
<0.0001 |
| Income category (monthly) |
|
|
|
|
|
| |
≤ USD 800 |
Reference |
|
Reference |
|
| > USD 800 | 0.58 (0.36-0.93) | 0.023 | 0.63 (0.58-0.68) | <0.0001 |
aHR: Hazard ratio. Adjusted by Charlson comorbidity index, time-dependent covariate for herpes zoster group, and income category.
bPresence of any comorbidities listed in Charlson comorbidity index.